Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 22Neoplasms 20Lung Neoplasms 10Colorectal Neoplasms 8Uterine Cervical Neoplasms 6Papillomavirus Infections 5Head and Neck Neoplasms 5Fatigue 5Multiple Myeloma 4Lymphoma 4Hematologic Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Prostatic Neoplasms 3Melanoma 3Hematopoietic and Lymphoid System Neoplasm 3Gastrointestinal Neoplasms 3Sleep Wake Disorders 2Skin Cancer Prevention 2Obesity 2Neoplasm Metastasis 2Motor Activity 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hematopoietic and Lymphatic System Neoplasm 2Diabetes Mellitus 2Depression 2Caregiver 2Cancer Survivor 2

Interventions

fludarabine phosphate 13Cyclophosphamide 13fludarabine 10Whole-Body Irradiation 10Melphalan 10Tacrolimus 9Busulfan 9Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Alemtuzumab 5Cyclosporine 4Antilymphocyte Serum 4Stem Cell Transplantation 3Methotrexate 3Granulocyte Colony-Stimulating Factor 3thymoglobulin 2sargramostim 2Thiotepa 2Rituximab 2Methylprednisolone 2Filgrastim 2posaconazole 1methanesulfonic acid 1merphos 1ibrutinib 1Transplantation, Homologous 1Transplantation 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia, Aplastic × Educational Status × Clear all
NCT05972577 2026-04-06

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡